π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
A ten week, blinded trial of vitamin D vs. placebo in 80 patients with schi...
Status
Withdrawn
Location
Bellevue Hospital Center
Start Date
2015-02
Trial ID
NCT02197286
Treatments Being Tested
This project aimed to test the efficacy of a telehealth-administered placeb...
Status
Completed
Location
Michigan State University
Start Date
2021-02-04
Trial ID
NCT05035550
Treatments Being Tested
This is a prospective, single-center, randomized, double-blind, placebo-con...
Status
Terminated
Location
Mayo Clinic
Start Date
2022-11-10
Trial ID
NCT04925960
Treatments Being Tested
Patients with diabetes are at increased risk of developing heart failure (H...
Status
Completed
Location
Ninewells Hospital and Medical School
Start Date
2015-03
Trial ID
NCT02397421
Treatments Being Tested
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
Open label pharmacokinetic RBT dose-finding study in young (β€ 5 year old) H...
Status
Unknown
Location
Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, WHI, University of the Witwatersrand
Start Date
2010-11
Trial ID
NCT01259219
Treatments Being Tested
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-28
Trial ID
NCT01031108
The goal of this randomized, single blind, two-armed pilot study is to asse...
Status
Completed
Location
Chronic Viral Illness Service
Start Date
2024-07-31
Trial ID
NCT06022406
Treatments Being Tested
The main purpose of the study is to see how safe SRT3025 (study drug) is wh...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-03
Trial ID
NCT01340911
This is a Phase I, single-center, open-label, fixed-sequence, 2-period cros...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03149848
Treatments Being Tested